Mindbloom, a telemedicine company that provides ketamine for depression and anxiety as part of a treatment program, is accused of negligence in the death of Philip Ward. But the facts leading up to his overdose are in dispute. 

The initial condolences were mailed out as a result of a computer error, a hospital spokesperson said. The recipients were never marked as deceased on any official records. 

The plaintiffs, 10 nurses and one doctor, are all enrolled in the state-mandated initiative for clinicians with past substance abuse issues. The rules require monitoring and regular drug testing to prove sobriety; however, the lot argues that the contractor in charge, Maximus, is being dishonestly punitive.

Clinicians who come to rely on AI for decision support risk the dulling of their skills. The concern is not new. But now comes a pointed call to researchers: Inquire about the particulars of the peril.

With patients gaining access to imaging reports earlier than ever, it's critical they have access to large language models that can accurately summarize the results.